Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy.
Authors
Ramin, CodyPfeiffer, Ruth M
Fan, Sharon
Mullooly, Maeve
Falk, Roni T
Jones, Kristine
Caporaso, Neil E
Bey-Knight, Lisa
Sak, Mark A
Simon, Michael S
Gorski, David H
Ali, Haythem
Littrup, Peter
Duric, Neb
Sherman, Mark E
Gierach, Gretchen L
Issue Date
2023-03-15Keywords
BREAST CANCERCancer epidemiology
endocrine symptoms
Metadata
Show full item recordJournal
NPJ breast cancerDOI
10.1038/s41523-023-00511-8PubMed ID
36922547Item Type
ArticleLanguage
enISSN
2374-4677ae974a485f413a2113503eed53cd6c53
10.1038/s41523-023-00511-8
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Related articles
- Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography.
- Authors: Gierach GL, Sak M, Fan S, Pfeiffer RM, Palakal M, Ramin C, Bey-Knight L, Simon MS, Gorski D, Ali H, Littrup P, Sherman ME, Duric N
- Issue date: 2022 Feb 1
- Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
- Authors: Atakpa EC, Thorat MA, Cuzick J, Brentnall AR
- Issue date: 2021 Oct 26
- CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial.
- Authors: He W, Eriksson M, Eliasson E, Grassmann F, Bäcklund M, Gabrielson M, Hammarström M, Margolin S, Thorén L, Wengström Y, Borgquist S, Hall P, Czene K
- Issue date: 2021 Oct
- Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
- Authors: Dar H, Johansson A, Nordenskjöld A, Iftimi A, Yau C, Perez-Tenorio G, Benz C, Nordenskjöld B, Stål O, Esserman LJ, Fornander T, Lindström LS
- Issue date: 2021 Jun 1
- Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.
- Authors: Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Gierach GL
- Issue date: 2015 Mar